Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

8.46
Delayed Data
As of Jul 30
 +0.03 / +0.36%
Today’s Change
4.26
Today|||52-Week Range
11.15
+11.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash6.0M0.005.5M119.3M
 
 
 
 
Short Term Investment Cash22.2M-11.3M7.0M53.4M
 
 
 
 
 
Cash & Short Term Investments70.1M58.8M65.9M119.3M
 
 
 
 
 
 
ReceivablesReceivables2.4M6.9M2.9M109.0K
 
 
 
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets0.001.7M1.9M2.5M
 
 
 
 
Current Assets72.5M67.5M70.7M121.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross26.1M15.7M14.5M12.4M
 
 
 
 
 
Depreciation-22.1M-12.3M-12.1M-9.8M
 
 
 
 
 
Intangible Assets0.000.0039.1M36.4M
 
 
 
Other Assets0.00150.0K39.1M36.6M
 
 
 
 
Total Assets80.1M76.3M114.5M161.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable309.0K229.0K793.0K1.0M
 
 
 
 
 
Accrued Expenses2.9M3.0M3.6M3.8M
 
 
 
 
 
Other Current Liabilities3.2M4.0M3.7M3.9M
 
 
 
 
 
Other Liabilities6.7M8.7M6.6M6.7M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes0.00-2.1M-12.3M-11.3M
 
 
 
 
Other Liabilities1.5M1.1M914.0K17.2M
 
 
 
 
 
Total Liabilities8.3M9.7M35.6M36.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity71.8M66.6M79.0M124.9M
 
 
 
 
 
Total Shareholder Equity71.8M66.6M79.0M124.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding33.8M46.6M60.8M69.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.